The accumulation of MDSC in tumor-bearing individuals has been shown to depend on the inflammatory mediators IL-1β, IL-6, and Prostaglandin-E2 (PGE2) [114,115,116,117,118]. This evidence concerns the gene IL6 and neoplasm.